Skip To Main Content
von Bardeleben on Muck Rack

von Bardeleben

As seen in: Frontiers, Medical Dialogues, The European Heart Journal Podcast
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with von

Contact von, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Dapagliflozin and Sitagliptin FDC in T2D with Heart Failure: 2025 Indian Practice Review Dr Santosh H S

|
By Pramod Kumar, Di Angelantonio, von Bardeleben, Santosh H.S
| Medical Dialogues
Among India's 89.8 million people with T2D [1], heart failure incidence reaches approximately 50%, with 33% higher hospitalization risk versus non-diabetics; with undiagnosed HF further adding to this brunt. [2] Poor glycemic control incrementally increases HF risk with each 1% HbA1c elevation. [3] The clinical challenge lies in achieving glycemic targets while avoiding agents that may worsen cardiac function.
Open in Who Shared Issue with article?

Hospitalizations in symptomatic patients with heart failure and moderate to severe functional mitral regurgitation: insights from RESHAPE-HF2

|
By von Bardeleben, Ralph Stephan, Muhammad Shahzeb, P. Christian
| gla.ac.uk
Ponikowski, P. et al. (2024) Hospitalizations in symptomatic patients with heart failure and moderate to severe functional mitral regurgitation: insights from RESHAPE-HF2. JACC: Heart Failure, (Accepted for Publication) Full text not currently available from Enlighten. Item Type: Articles Status: Accepted for Publication Refereed: Yes Glasgow Author(s) Enlighten ID: Cleland, Professor John and Petrie, Professor Mark Authors: Ponikowski, P., Friede, T., von Bardeleben, R. S., Butler, J., Khan, M.
Open in Who Shared Issue with article?

Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE-HF2 trial and comparison to COAPT and MITRA-FR trials

|
By von Bardeleben, Ralph Stephan, Muhammad Shahzeb, John G.F
| gla.ac.uk
Anker, S. D. et al. (2024) Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE-HF2 trial and comparison to COAPT and MITRA-FR trials. European Journal of Heart Failure, 26(7), pp. 1608-1615. (doi: 10.1002/ejhf.3286) (PMID:38847420) Text 331366.pdf - Published Version Available under License Creative Commons Attribution Non-commercial No Derivatives.
Open in Who Shared Issue with article?
See all 8 licensed articles (9 Total)